======= MCC ======= == Gene Information == * **Official Symbol**: MCC * **Official Name**: MCC regulator of WNT signaling pathway * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4163|4163]] * **UniProt**: [[https://www.uniprot.org/uniprot/P23508|P23508]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MCC&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MCC|Open PubMed]] * **OMIM**: [[https://omim.org/entry/159350|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a candidate colorectal tumor suppressor gene that is thought to negatively regulate cell cycle progression. The orthologous gene in the mouse expresses a phosphoprotein associated with the plasma membrane and membrane organelles, and overexpression of the mouse protein inhibits entry into S phase. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Candidate for the putative colorectal tumor suppressor gene located at 5q21. Suppresses cell proliferation and the Wnt/b- catenin pathway in colorectal cancer cells. Inhibits DNA binding of b-catenin/TCF/LEF transcription factors. Involved in cell migration independently of RAC1, CDC42 and p21-activated kinase (PAK) activation (PubMed:18591935, PubMed:19555689, PubMed:22480440). Represses the beta-catenin pathway (canonical Wnt signaling pathway) in a CCAR2-dependent manner by sequestering CCAR2 to the cytoplasm, thereby impairing its ability to inhibit SIRT1 which is involved in the deacetylation and negative regulation of beta-catenin (CTNB1) transcriptional activity (PubMed:24824780). {ECO:0000269|PubMed:18591935, ECO:0000269|PubMed:19555689, ECO:0000269|PubMed:22480440, ECO:0000269|PubMed:24824780}. |MCC-bdg PDZ| |negative regulation of epithelial cell migration| |negative regulation of epithelial cell proliferation| |negative regulation of canonical Wnt signaling pathway| |lamellipodium| |signaling receptor activity| |negative regulation of Wnt signaling pathway| |regulation of epithelial cell migration| |negative regulation of cell migration| |negative regulation of cell motility| |regulation of canonical Wnt signaling pathway| |negative regulation of cellular component movement| |negative regulation of locomotion| |regulation of epithelial cell proliferation| |Wnt signaling pathway| |cell-cell signaling by wnt| |regulation of Wnt signaling pathway| |cell surface receptor signaling pathway involved in cell-cell signaling| |negative regulation of cell population proliferation| |regulation of cell migration| |regulation of cell motility| |regulation of locomotion| |regulation of cellular component movement| |cell-cell signaling| |negative regulation of multicellular organismal process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |establishment of protein localization| |regulation of cell population proliferation| |negative regulation of response to stimulus| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.77| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7044 * **Expression level (log2 read counts)**: 2.31 {{:chemogenomics:nalm6 dist.png?nolink |}}